• ABOUT Handa
    • Our Company
    • Leadership Team
    • Careers
  • R&D
    • Pipeline
    • Resources
  • Products
  • Partnering
  • RECENT NEWS
  • CONTACT
  • ABOUT Handa
    • Our Company
    • Leadership Team
    • Careers
  • R&D
    • Pipeline
    • Resources
  • Products
  • Partnering
  • RECENT NEWS
  • CONTACT

RECENT NEWS

Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO (dasatinib) Tablets

2025-01-15

P 510.354.2888   |   F 510.354.2887   |   info@handapharma.com
© 2020 Handa Pharma, Inc.